Patent · US Active

Methods for treating cholestasis

US11497745B2 · kind B2 · utility

1Cited by
2References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2021
Grant dateNov 15, 2022
Priority date
Expiry dateDec 17, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/085
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods for treating cholestasis in a subject having a liver disease. The method includes administering to the subject an Apical Sodium-dependent Bile Acid Transporter (ASBTI). More specifically, the present invention relates to methods for treating cholestasis in a subject where the method includes administering an ASBTI to a subject at a dose of at least 10 μg/kg/day.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.